Assessment of the degree of adherence of medical laboratories to KDIGO 2012 guideline for evaluation and management of CKD in Czechia and Slovakia

. 2019 Oct 15 ; 29 (3) : 030704. [epub] 20190805

Jazyk angličtina Země Chorvatsko Médium print-electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid31379462

INTRODUCTION: The aim of the study is to assess the degree of adherence of medical laboratories to Kidney Disease Improving Global Outcomes (KDIGO) 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (CKD) in laboratory practice in Czechia and Slovakia. MATERIALS AND METHODS: An electronic questionnaire on adherence to KDIGO 2012 guideline was designed by an external quality assessment (EQA) provider SEKK spol. s.r.o. The questionnaire was placed and distributed through website to all medical biochemistry laboratories in Czechia and Slovakia (N = 396). RESULTS: A total of 212 out of 396 laboratories responded to the questions, though some laboratories only answered some questions, those applicable to their practice. A total of 48 out of 212 laboratories adopted the KDIGO 2012 guideline in full extent. The metrological traceability of creatinine measurement to standard reference material of SRM 967 was declared by 180 out of 210 laboratories (two of the responding laboratories did not measure creatinine). Thirty laboratories are not well educated on traceability of creatinine measurement and seven laboratories do not calculate estimated glomerular filtration rate (eGFR). Both urinary albumin concentration and albumin to creatinine ratio are reported by 144 out of 175 laboratories (37 of the responding laboratories did not measure urinary albumin). CONCLUSION: Majority of laboratories in Czechia and Slovakia adopted some parts of the KDIGO 2012 guideline in their practice, but only 23% of the laboratories apply them completely. Thus, further education and action should be conducted to improve its implementation.

Erratum v

PubMed

Zobrazit více v PubMed

Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150.

Wang F, He K, Wang J, Zhao MH, Li Y, Zhang L, et al. Prevalence and Risk Factors for CKD: A Comparison Between the Adult Populations in China and the United States. Kidney Int Rep. 2018;3:1135–43. 10.1016/j.ekir.2018.05.011 PubMed DOI PMC

Brück K, Stel VS, Gambaro G, Hallan S, Völzke H, Ärnlöv J, et al. CKD Prevalence Varies across the European General Population. J Am Soc Nephrol. 2016;27:2135–47. 10.1681/ASN.2015050542 PubMed DOI PMC

Sikorska D, Grzymislawska M, Roszak M, Gulbicka P, Korybalska K, Witowski J. Simple obesity and renal function. J Physiol Pharmacol. 2017;68:175–80. PubMed

Astor BC, Hallan SI, Miller ER, 3rd, Yeung E, Coresh J. Glomerular Filtration Rate, Albuminuria, and Risk of Cardiovascular and All-Cause Mortality in the US Population. Am J Epidemiol. 2008;167:1226–34. 10.1093/aje/kwn033 PubMed DOI

Dodder NG, Tai SS, Sniegoski LT, Zhang NF, Welch MJ. Certification of Creatinine in a Human Serum Reference Material by GC-MS and LC-MS. Clin Chem. 2007;53:1694–9. 10.1373/clinchem.2007.090027 PubMed DOI

Grubb A, Blirup-Jensen S, Lindström V, Schmidt C, Althaus H, Zegers I. IFCC Working Group on Standardisation of Cystatin C (WG-SCC). First certified reference material for cystatin C in human serum ERM-DA471/IFCC. Clin Chem Lab Med. 2010;48:1619–21. 10.1515/CCLM.2010.318 PubMed DOI

Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J. 2016;37:2999–3058. 10.1093/eurheartj/ehw272 PubMed DOI

Zima T, Racek J, Tesař V, Viklicky O, Teplan V, Schuck, et al. [Doporučeni k diagnostice chronického onemocněni ledvin (odhad glomerularni filtrace a vyšetřovani proteinurie) Česke nefrologicke společnosti ČLS JEP a Česke společnosti klinicke biochemie ČLS JEP] Klin Biochem Metab. 2014;22:138–52. [in Czech]

Biljak VR, Honović L, Matica J, Knežević B, Vojak SŠ. Laboratory diagnostics of chronic kidney disease in Croatia: state of the art. Biochem Med (Zagreb). 2015;25:73–83. 10.11613/BM.2015.009 PubMed DOI PMC

Drion I, Cobbaert C, Groenier KH, Weykamp C, Bilo HJ, Wetzels JF, et al. Clinical evaluation of analytical variations in serum creatinine measurements: why laboratories should abandon Jaffe techniques. BMC Nephrol. 2012;13:133. 10.1186/1471-2369-13-133 PubMed DOI PMC

Surveys Clinical chemical analytes in serum “wet chemistry” 2019. Reference Institute of Bioanalytics. Available at: https://www.rfb.bio/cgi/displayAnaStats?rv_type=KS&rvTypeForDetails=KS&year=2019&rv_num=1&analyte=all&searchType=rv_type&anaV=7. Accessed February 15th 2019.

Salek T, Vesely P, Bernatek J. Estimated Glomerular Filtration Rate in Oncology Patients before Cisplatin Chemotherapy. Klin Onkol. 2015;28:273–7. 10.14735/amko2015273 PubMed DOI

Grubb A, Horio M, Hansson L-O, Björk J, Nyman U, Flodin M, et al. Generation of a New Cystatin C–Based Estimating Equation for Glomerular Filtration Rate by Use of 7 Assays Standardized to the International Calibrator. Clin Chem. 2014;60:974–86. 10.1373/clinchem.2013.220707 PubMed DOI

Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–70. 10.7326/0003-4819-130-6-199903160-00002 PubMed DOI

Fuček M, Dika Ž, Karanović S, Vuković Brinar I, Premužić V, Kos J, et al. Reliability of CKD-EPI predictive equation in estimating chronic kidney disease prevalence in the Croatian endemic nephropathy area. Biochem Med (Zagreb). 2018;28:010701. 10.11613/BM.2018.010701 PubMed DOI PMC

Björk J, Bäck SE, Sterner G, Carlson J, Lindstrom V, Bakoush O, et al. Prediction of relative glomerular filtration rate in adults: new improved equations based on Swedish Caucasians and standardized plasma-creatinine assays. Scand J Clin Lab Invest. 2007;67:678–95. 10.1080/00365510701326891 PubMed DOI

Manns L, Scott-Douglas N, Tonelli M, Weaver R, Tam-Tham H, Chong C, et al. A Population-Based Analysis of Quality Indicators in CKD. Clin J Am Soc Nephrol. 2017;12:727–33. 10.2215/CJN.08720816 PubMed DOI PMC

Fung CS, Wan EY, Chan AK, Lam CL. Association of estimated glomerular filtration rate and urine albumin-to-creatinine ratio with incidence of cardiovascular diseases and mortality in chinese patients with type 2 diabetes mellitus - a population-based retrospective cohort study. BMC Nephrol. 2017;18:47. 10.1186/s12882-017-0468-y PubMed DOI PMC

Ćelap I, Vukasović I, Juričić G, Šimundić AM. Minimum requirements for the estimation of measurement uncertainty: Recommendations of the joint Working group for uncertainty of measurement of the CSMBLM and CCMB. Biochem Med (Zagreb). 2017;27:030502. htps://.10.11613/BM.2017.030502 PubMed DOI PMC

The New International Recommendations for Chronic Kidney Disease. Available at: https://www.aacc.org/publications/cln/articles/2014/october/kidney-disease. Accessed January 16th 2019.

Biljak VR, Honović L, Matica J, Krešić B, Vojak SŠ. The role of laboratory testing in detection and classification of chronic kidney disease: national recommendations. Biochem Med (Zagreb). 2017;27:153–76. 10.11613/BM.2017.019 PubMed DOI PMC

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace